400
Views
0
CrossRef citations to date
0
Altmetric
Review

Developments in the prediction of cognitive changes following deep brain stimulation in persons with Parkinson’s disease

Pages 643-659 | Received 29 Mar 2024, Accepted 22 May 2024, Published online: 30 May 2024

References

  • Dafsari HS, Reker P, Stalinski L, et al. Quality of life outcome after subthalamic stimulation in parkinson’s disease depends on age. Mov Disord. 2018 Jan;33(1):99–107. doi: 10.1002/mds.27222
  • Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for parkinson’s disease. N Engl J Med. [2006 Aug 31];355(9):896–908. doi: 10.1056/NEJMoa060281
  • Okun MS, Gallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant-current device in parkinson’s disease: an open-label randomised controlled trial. Lancet Neurol. 2012 Feb;11(2):140–149. doi: 10.1016/S1474-4422(11)70308-8
  • Vitek JL, Jain R, Chen L, et al. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in parkinson’s disease (intrepid): a multicentre, double-blind, randomised, sham-controlled study. Lancet Neurol. 2020 Jun;19(6):491–501. doi: 10.1016/S1474-4422(20)30108-3
  • Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced parkinson disease: a randomized controlled trial. JAMA. [2009 Jan 7];301(1):63–73. doi: 10.1001/jama.2008.929
  • Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced parkinson’s disease (pd surg trial): a randomised, open-label trial. Lancet Neurol. 2010 Jun;9(6):581–591. doi: 10.1016/S1474-4422(10)70093-4
  • Martinez-Martin P, Deuschl G, Tonder L, et al. Interpretation of health-related quality of life outcomes in parkinson’s disease from the earlystim study. PLOS ONE. 2020;15(8):e0237498. doi: 10.1371/journal.pone.0237498
  • Lachenmayer ML, Murset M, Antih N, et al. Subthalamic and pallidal deep brain stimulation for parkinson’s disease-meta-analysis of outcomes. NPJ Parkinsons Dis. [2021 Sep 6];7(1):77. doi: 10.1038/s41531-021-00223-5
  • Bratsos S, Karponis D, Saleh SN. Efficacy and safety of deep brain stimulation in the treatment of parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials. Cureus. [2018 Oct 22];10(10):e3474. doi: 10.7759/cureus.3474
  • Jahanshahi M, Leimbach F, Rawji V. Short and long-term cognitive effects of subthalamic deep brain stimulation in parkinson’s disease and identification of relevant factors. J Parkinsons Dis. 2022;12(7):2191–2209. doi: 10.3233/JPD-223446
  • Racki V, Hero M, Rozmaric G, et al. Cognitive impact of deep brain stimulation in parkinson’s disease patients: A systematic review. Front Hum Neurosci. 2022;16:867055. doi: 10.3389/fnhum.2022.867055
  • Bucur M, Papagno C. Deep brain stimulation in parkinson disease: A meta-analysis of the long-term neuropsychological outcomes. Neuropsychol rev. 2023 Jun;33(2):307–346. doi: 10.1007/s11065-022-09540-9
  • Geraedts VJ, Feleus S, Marinus J, et al. What predicts quality of life after subthalamic deep brain stimulation in parkinson’s disease? A systematic review. Eur J Neurol. 2020 Mar;27(3):419–428. doi: 10.1111/ene.14147
  • Cartmill T, Skvarc D, Bittar R, et al. Deep brain stimulation of the subthalamic nucleus in parkinson’s disease: a meta-analysis of mood effects. Neuropsychol rev. 2021 Sep;31(3):385–401. doi: 10.1007/s11065-020-09467-z
  • Lo Buono V, Luca Trombetta M, Palmeri R, et al. Subthalamic nucleus deep brain stimulation and impulsivity in parkinson’s disease: A descriptive review. Acta Neurol Belg. 2021 Aug;121(4):837–847. doi: 10.1007/s13760-021-01684-4
  • Wilt JA, Merner AR, Zeigler J, et al. Does personality change follow deep brain stimulation in parkinson’s disease patients? Front Psychol. 2021;12:643277. doi: 10.3389/fpsyg.2021.643277
  • Lang AE, Houeto JL, Krack P, et al. Deep brain stimulation: Preoperative issues. Mov Disord. 2006 Jun;21(Suppl 14):S171–96. doi: 10.1002/mds.20955
  • Caparros-Lefebvre D, Blond S, Pécheux N, et al. Evaluation neuropsychologique avant et après stimulation thalamique chez 9 parkinsoniens. Rev Neurol (Paris). 1992;148(2):117–122.
  • Tröster AI, Fields JA, Wilkinson SB, et al. Neuropsychological functioning before and after unilateral thalamic stimulating electrode implantation in parkinson’s disease [electronic manuscript]. Neurosurg Focus. 1997;2(3):Article 9 (pp. 1–6. doi: 10.3171/foc.1997.2.3.12
  • Woods SP, Fields JA, Lyons KE, et al. Neuropsychological and quality of life changes following unilateral thalamic deep brain stimulation in parkinson’s disease: A 12-month follow-up. Acta Neurochir (Wien). 2001;143(12):1273–1278. doi: 10.1007/s007010100024
  • Merello M, Nouzeilles MI, Kuzis G, et al. Unilateral radiofrequency lesion versus electrostimulation of posteroventral pallidum: a prospective randomized comparison. Mov Disord. 1999;14(1):50–56. doi: 10.1002/1531-8257(199901)14:1<50:AID-MDS1010>3.0.CO;2-6
  • Tröster AI, Fields JA, Wilkinson SB, et al. Unilateral pallidal stimulation for parkinson’s disease: Neurobehavioral functioning before and 3 months after electrode implantation. Neurology. 1997;49(4):1078–1083. doi: 10.1212/WNL.49.4.1078
  • Vingerhoets G, van der Linden C, Lannoo E, et al. Cognitive outcome after unilateral pallidal stimulation in parkinson’s disease. J Neurol Neurosurg Psychiatry. 1999;66(3):297–304. doi: 10.1136/jnnp.66.3.297
  • Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in parkinson’s disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The compare trial. Ann Neurol. 2009 May;65(5):586–595. doi: 10.1002/ana.21596
  • Fields JA, Tröster AI, Wilkinson SB, et al. Cognitive outcome following staged bilateral pallidal stimulation for the treatment of parkinson’s disease. Clin Neurol Neurosur. 1999;101(3):182–188. doi: 10.1016/S0303-8467(99)00044-X
  • Rothlind JC, Cockshott RW, Starr PA, et al. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for parkinson’s disease. J Int Neuropsychol Soc. 2007 Jan;13(1):68–79. doi: 10.1017/S1355617707070105
  • Ardouin C, Pillon B, Peiffer E, et al. Bilateral subthalamic or pallidal stimulation for parkinson’s disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol. 1999;46(2):217–223. doi: 10.1002/1531-8249(199908)46:2<217:AID-ANA11>3.0.CO;2-Z
  • Pillon B, Ardouin C, Damier P, et al. Neuropsychological changes between “off” and “on” stn or gpi stimulation in parkinson’s disease. Neurology. 2000;55(3):411–418. doi: 10.1212/WNL.55.3.411
  • Odekerken VJ, Boel JA, Geurtsen GJ, et al. Neuropsychological outcome after deep brain stimulation for parkinson disease. Neurology. 2015 Mar 31;84(13):1355–1361. doi: 10.1212/WNL.0000000000001419
  • Rothlind JC, York MK, Carlson K, et al. Neuropsychological changes following deep brain stimulation surgery for parkinson’s disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):622–629. doi: 10.1136/jnnp-2014-308119
  • Combs HL, Folley BS, Berry DT, et al. Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in parkinson’s disease: A meta-analysis. Neuropsychol rev. 2015 Dec;25(4):439–454. doi: 10.1007/s11065-015-9302-0
  • Bonenfant J, Drapier S, Houvenaghel JF, et al. Pallidal stimulation in parkinson’s patients with contraindications to subthalamic target: a 3 years follow-up. Parkinsonism Relat Disord. 2017 Jan;34:20–25. doi: 10.1016/j.parkreldis.2016.10.007
  • Rughani A, Schwalb JM, Sidiropoulos C, et al. Congress of neurological surgeons systematic review and evidence-based guideline on subthalamic nucleus and globus pallidus internus deep brain stimulation for the treatment of patients with parkinson’s disease: Executive summary. Neurosurgery. [2018 Jun 1];82(6):753–756. doi: 10.1093/neuros/nyy037
  • Elgebaly A, Elfil M, Attia A, et al. Neuropsychological performance changes following subthalamic versus pallidal deep brain stimulation in parkinson’s disease: a systematic review and metaanalysis. CNS Spectr. 2017 Feb;23(1):10–23. doi: 10.1017/S1092852917000062
  • Wang JW, Zhang YQ, Zhang XH, et al. Cognitive and psychiatric effects of stn versus gpi deep brain stimulation in parkinson’s disease: a meta-analysis of randomized controlled trials. PLOS ONE. 2016;11(6):e0156721. doi: 10.1371/journal.pone.0156721
  • Tröster AI, McTaggart AB, Heber IA. Neuropsychological issues in deep brain stimulation of neurological and psychiatric disorders. In: Tarsy D, Vitek J, and Starr P, editors. Deep brain stimulation in neurological and psychiatric disorders. (NY): Springer; 2008. p. 399–452.
  • Parsons TD, Rogers SA, Braaten AJ, et al. Cognitive sequelae of subthalamic nucleus deep brain stimulation in parkinson’s disease: A meta-analysis. Lancet Neurol. 2006 Jul;5(7):578–588. doi: 10.1016/S1474-4422(06)70475-6
  • Tramontana MG, Molinari AL, Konrad PE, et al. Neuropsychological effects of deep brain stimulation in subjects with early stage parkinson’s disease in a randomized clinical trial. J Parkinsons Dis. 2015;5(1):151–163. doi: 10.3233/JPD-140448
  • Cobb JL, Wolf PA, Au R, et al. The effect of education on the incidence of dementia and alzheimer’s disease in the framingham study. Neurology. 1995;45(9):1707–1712. doi: 10.1212/WNL.45.9.1707
  • Martinez-Martinez AM, Aguilar OM, Acevedo-Triana CA. Meta-analysis of the relationship between deep brain stimulation in patients with parkinson’s disease and performance in evaluation tests for executive brain functions. Parkinsons Dis. 2017;2017:9641392. doi: 10.1155/2017/9641392
  • Xie Y, Meng X, Xiao J, et al. Cognitive changes following bilateral deep brain stimulation of subthalamic nucleus in parkinson’s disease: A meta-analysis. Biomed Res Int. 2016;2016:3596415. doi: 10.1155/2016/3596415
  • Tröster AI. Some clinically useful information that neuropsychology provides patients, carepartners, neurologists, and neurosurgeons about deep brain stimulation for parkinson’s disease. Arch Clin Neuropsychol. [2017 Nov 1];32(7):810–828. doi: 10.1093/arclin/acx090
  • Meader N, King K, Llewellyn A, et al. A checklist designed to aid consistency and reproducibility of grade assessments: Development and pilot validation. Syst Rev. [2014 Jul 24];3(1):82. doi: 10.1186/2046-4053-3-82
  • Philipson J, Blomstedt P, Fredricks A, et al. Short- and long-term cognitive effects of deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with parkinson’s disease. J Neurosurg. [2020 Feb 7];134(2):357–365. doi: 10.3171/2019.12.JNS192654
  • Ricciardi L, Sarchioto M, Morgante F. Role of pedunculopontine nucleus in sleep-wake cycle and cognition in humans: A systematic review of dbs studies. Neurobiol Dis. 2019 Aug;128:53–58. doi: 10.1016/j.nbd.2019.01.022
  • Tröster AI, Ponce FA, Moguel-Cobos G. Deep-brain stimulation for parkinson’s disease: Current perspectives on patient selection with an emphasis on neuropsychology. JPRLS. 2018 Nov 17;8(null):33–48. doi: 10.2147/JPRLS.S125332
  • Abboud H, Floden D, Thompson NR, et al. Impact of mild cognitive impairment on outcome following deep brain stimulation surgery for parkinson’s disease. Parkinsonism Relat Disord. 2015 Mar;21(3):249–253. doi: 10.1016/j.parkreldis.2014.12.018
  • Alhourani A, Wylie SA, Summers JE, et al. Developing predictor models of postoperative verbal fluency after deep brain stimulation using preoperative neuropsychological assessment. Neurosurgery. [2022 Aug 1];91(2):256–262. doi: 10.1227/neu.0000000000001964
  • Askari A, Greif TR, Lam J, et al. Decline of verbal fluency with lateral superior frontal gyrus penetration in subthalamic nucleus deep brain stimulation for parkinson disease. J Neurosurg. 2022Jan 28;137:729–734.
  • Bjerknes S, Toft M, Brandt R, et al. Subthalamic nucleus stimulation in parkinson’s disease: 5-year extension study of a randomized trial. Mov Disord Clin Pract. 2022 Jan;9(1):48–59. doi: 10.1002/mdc3.13348
  • Blume J, Lange M, Rothenfusser E, et al. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in parkinson’s disease. Clin Neurol Neurosur. [2017 May 31];159:87–92. doi: 10.1016/j.clineuro.2017.05.023
  • Bot M, van den Munckhof P, Schmand BA, et al. Electrode penetration of the caudate nucleus in deep brain stimulation surgery for parkinson’s disease. Stereotact Funct Neurosurg. 2018;96(4):223–230. doi: 10.1159/000489944
  • Brown G, Du G, Farace E, et al. Subcortical iron accumulation pattern may predict neuropsychological outcomes after subthalamic nucleus deep brain stimulation: a pilot study. J Parkinsons Dis. 2022;12(3):851–863. doi: 10.3233/JPD-212833
  • Clement G, Wirth T, Haumesser L, et al. Language and verbal fluency outcome after bilateral subthalamic nucleus deep brain stimulation in parkinson’s disease. Parkinsonism Relat Disord. 2022 Dec;105:15–18. doi: 10.1016/j.parkreldis.2022.10.023
  • Costentin G, Derrey S, Gerardin E, et al. White matter tracts lesions and decline of verbal fluency after deep brain stimulation in parkinson’s disease. Hum Brain Mapp. [2019 Jun 15];40(9):2561–2570. doi: 10.1002/hbm.24544
  • Daniels C, Krack P, Volkmann J, et al. Risk factors for executive dysfunction after subthalamic nucleus stimulation in parkinson’s disease. Mov Disord. 2010;25(11):1583–1589. doi: 10.1002/mds.23078
  • Floden DP, Matias CM, Wathen CA, et al. Contact location and neuropsychological outcomes in subthalamic deep brain stimulation. Neurosurgery. [2017 Oct 18];83(4):666–674. doi: 10.1093/neuros/nyx475
  • Foley JA, Foltynie T, Zrinzo L, et al. Apathy and reduced speed of processing underlie decline in verbal fluency following dbs. Behav Neurol. 2017;2017:1–10. doi: 10.1155/2017/7348101
  • Francel P, Ryder K, Wetmore J, et al. Deep brain stimulation for parkinson’s disease: Association between stimulation parameters and cognitive performance. Stereotact Funct Neurosurg. 2004;82(4):191–193. doi: 10.1159/000082208
  • Fukaya C, Watanabe M, Kobayashi K, et al. Predictive factors for long-term outcome of subthalamic nucleus deep brain stimulation for parkinson’s disease. Neurol Med Chir (Tokyo). [2017 Apr 15];57(4):166–171. doi: 10.2176/nmc.oa.2016-0114
  • Kubler D, Wellmann SK, Kaminski J, et al. Nucleus basalis of meynert predicts cognition after deep brain stimulation in parkinson’s disease. Parkinsonism Relat Disord. 2022 Jan;94:89–95. doi: 10.1016/j.parkreldis.2021.12.002
  • Geraedts VJ, Koch M, Kuiper R, et al. Preoperative electroencephalography-based machine learning predicts cognitive deterioration after subthalamic deep brain stimulation. Mov Disord. 2021 Oct;36(10):2324–2334. doi: 10.1002/mds.28661
  • Greif TR, Askari A, Cook Maher A, et al. Anterior lead location predicts verbal fluency decline following stn-dbs in parkinson’s disease. Parkinsonism Relat Disord. 2021 Nov;92:36–40. doi: 10.1016/j.parkreldis.2021.10.012
  • Gruber D, Calmbach L, Kuhn AA, et al. Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in parkinson’s disease. J Neural Transm (Vienna). 2019 Mar;126(3):309–318. doi: 10.1007/s00702-019-01972-7
  • Hrabovsky D, Balaz M, Rab M, et al. Factors responsible for early postoperative mental alterations after bilateral implantation of subthalamic electrodes. Br J Neurosurg. 2017 Apr;31(2):212–216. doi: 10.1080/02688697.2016.1226256
  • Isler C, Albi A, Schaper FL, et al. Neuropsychological outcome in subthalamic nucleus stimulation surgeries with electrodes passing through the caudate nucleus. Stereotact Funct Neurosurg. 2016;94(6):413–420. doi: 10.1159/000453278
  • John KD, Wylie SA, Dawant BM, et al. Deep brain stimulation effects on verbal fluency dissociated by target and active contact location. Ann Clin Transl Neurol. 2021 Mar;8(3):613–622. doi: 10.1002/acn3.51304
  • Kim HJ, Jeon BS, Paek SH, et al. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in parkinson’s disease. J Neurol. 2014 Jun;261(6):1090–1096. doi: 10.1007/s00415-014-7321-z
  • Kratter IH, Karp JF, Chang YF, et al. Association of preoperative visual hallucinations with cognitive decline after deep brain stimulation for parkinson’s disease. J Neuropsychiatry Clin Neurosci. 2021 Spring;33(2):144–151. doi: 10.1176/appi.neuropsych.20040077
  • Kratter IH, Jorge A, Feyder MT, et al. Depression history modulates effects of subthalamic nucleus topography on neuropsychological outcomes of deep brain stimulation for parkinson’s disease. Transl Psychiatry. [2022 May 27];12(1):213. doi: 10.1038/s41398-022-01978-y
  • Le Goff F, Derrey S, Lefaucheur R, et al. Decline in verbal fluency after subthalamic nucleus deep brain stimulation in parkinson’s disease: A microlesion effect of the electrode trajectory? J Parkinsons Dis. [2015 Jan 1];5(1):95–104. doi: 10.3233/JPD-140443
  • Mangone G, Bekadar S, Cormier-Dequaire F, et al. Early cognitive decline after bilateral subthalamic deep brain stimulation in parkinson’s disease patients with gba mutations. Parkinsonism Relat Disord. 2020 Jul;76:56–62. doi: 10.1016/j.parkreldis.2020.04.002
  • Markser A, Maier F, Lewis CJ, et al. Deep brain stimulation and cognitive decline in parkinson’s disease: The predictive value of electroencephalography. J Neurol. 2015 Oct;262(10):2275–2284. doi: 10.1007/s00415-015-7839-8
  • Merola A, Rizzi L, Artusi CA, et al. Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients. J Neurol. 2014 Sep;261(9):1745–1751. doi: 10.1007/s00415-014-7414-8
  • Mulders AEP, Temel Y, Tonge M, et al. The association between surgical characteristics and cognitive decline following deep brain stimulation of the subthalamic nucleus in parkinson’s disease. Clin Neurol Neurosur. 2021 Jan;200:106341. doi: 10.1016/j.clineuro.2020.106341
  • Nimura T, Nagamatsu KI, Ando T, et al. An investigation into the effects and prognostic factors of cognitive decline following subthalamic nucleus stimulation in patients with parkinson’s disease. J Clin Neurosci. 2017 Oct;44:164–168. doi: 10.1016/j.jocn.2017.06.018
  • Pal G, Mangone G, Hill EJ, et al. Parkinson disease and subthalamic nucleus deep brain stimulation: Cognitive effects in gba mutation carriers. Ann Neurol. 2022 Mar;91(3):424–435. doi: 10.1002/ana.26302
  • Planche V, Munsch F, Pereira B, et al. Anatomical predictors of cognitive decline after subthalamic stimulation in parkinson’s disease. Brain Struct Funct. 2018 Sep;223(7):3063–3072. doi: 10.1007/s00429-018-1677-2
  • Rothlind JC, York MK, Luo P, et al. Predictors of multi-domain cognitive decline following dbs for treatment of parkinson’s disease. Parkinsonism Relat Disord. 2022 Feb;95:23–27. doi: 10.1016/j.parkreldis.2021.12.011
  • Saint-Cyr JA, Trépanier LL, Kumar R, et al. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in parkinson’s disease. Brain. 2000;123(10):2091–2108. doi: 10.1093/brain/123.10.2091
  • Sarno M, Gaztanaga W, Banerjee N, et al. Revisiting eligibility for deep brain stimulation: Do preoperative mood symptoms predict outcomes in parkinson’s disease patients? Parkinsonism Relat Disord. 2019 Jun;63:131–136. doi: 10.1016/j.parkreldis.2019.02.019
  • Schoenberg MR, Mash KM, Bharucha KJ, et al. Deep brain stimulation parameters associated with neuropsychological changes in subthalamic nucleus stimulation for refractory parkinson’s disease. Stereotact Funct Neurosurg. 2008;86(6):337–344. doi: 10.1159/000163554
  • Smeding HM, Speelman JD, Huizenga HM, et al. Predictors of cognitive and psychosocial outcome after stn dbs in parkinson’s disease. J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):754–760. doi: 10.1136/jnnp.2007.140012
  • Tesio V, Rizzi L, Jiang T, et al. Deep brain stimulation of the subthalamic nucleus in parkinson’s disease: Relationship between the electrode trajectory and cognitive decline. Parkinsonism Relat Disord. 2019 Apr;61:45–49. doi: 10.1016/j.parkreldis.2018.12.005
  • Tröster AI, Jankovic J, Tagliati M, et al. Neuropsychological outcomes from constant current deep brain stimulation for parkinson’s disease. Mov Disord. 2017 Mar;32(3):433–440. doi: 10.1002/mds.26827
  • Tsai ST, Lin SH, Lin SZ, et al. Neuropsychological effects after chronic subthalamic stimulation and the topography of the nucleus in parkinson’s disease. Neurosurgery. 2007 Nov;61(5):E1024–9; discussion E1029-30.doi: 10.1227/01.neu.0000303198.95296.6f
  • Voruz P, Pierce J, Ahrweiller K, et al. Motor symptom asymmetry predicts non-motor outcome and quality of life following stn dbs in parkinson’s disease. Sci Rep. [2022 Feb 22];12(1):3007. doi: 10.1038/s41598-022-07026-5
  • Voruz P, Haegelen C, Assal F, et al. Motor symptom asymmetry predicts cognitive and neuropsychiatric profile following deep brain stimulation of the subthalamic nucleus in parkinson’s disease: A 5-year longitudinal study. Arch Clin Neuropsychol. [2023 Aug 24];38(6):904–912. doi: 10.1093/arclin/acad013
  • Wang Z, You Z. Impacts of motor phenotype on cognitive function in patients with parkinson’s disease 1 year after subthalamic-nucleus deep brain stimulation. Geriatr Gerontol Int. 2023 Feb;23(2):85–90. doi: 10.1111/ggi.14524
  • Weinkle LJ, Hoyt B, Thompson JA, et al. Association of mri measurements with cognitive outcomes after stn-dbs in parkinson’s disease. Mov Disord Clin Pract. 2018 Jul;5(4):417–426. doi: 10.1002/mdc3.12643
  • Witt K, Daniels C, Krack P, et al. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in parkinson’s disease. J Neurol Sci. [2011 Nov 15];310(1–2):261–266. doi: 10.1016/j.jns.2011.06.028
  • Witt K, Granert O, Daniels C, et al. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in parkinson’s disease: Results from a randomized trial. Brain. 2013 Jul;136(Pt 7):2109–2119. doi: 10.1093/brain/awt151
  • Yaguez L, Costello A, Moriarty J, et al. Cognitive predictors of cognitive change following bilateral subthalamic nucleus deep brain stimulation in parkinson’s disease. J Clin Neurosci. 2014 Mar;21(3):445–450. doi: 10.1016/j.jocn.2013.06.005
  • Yakufujiang M, Higuchi Y, Aoyagi K, et al. Predictive potential of preoperative electroencephalogram for neuropsychological change following subthalamic nucleus deep brain stimulation in parkinson’s disease. Acta Neurochir (Wien). 2019 Oct;161(10):2049–2058. doi: 10.1007/s00701-019-03991-5
  • York MK, Wilde EA, Simpson R, et al. Relationship between neuropsychological outcome and dbs surgical trajectory and electrode location. J Neurol Sci. [2009 Dec 15];287(1–2):159–171. doi: 10.1016/j.jns.2009.08.003
  • Zhou Y, Fan T, Ma Y, et al. Association between baseline cognitive score and postoperative delirium in parkinson’s disease patients following deep brain stimulation surgery. Parkinsons Dis. 2022;2022:1–8. doi: 10.1155/2022/9755129
  • Geevarghese R, Lumsden DE, Costello A, et al. Verbal memory decline following dbs for parkinson’s disease: Structural volumetric mri relationships. PLoS One. 2016;11(8):e0160583. doi: 10.1371/journal.pone.0160583
  • Yakufujiang M, Higuchi Y, Aoyagi K, et al. Predicting neurocognitive change after bilateral deep brain stimulation of subthalamic nucleus for parkinson’s disease. World Neurosurg. 2021 Mar;147:e428–e436. doi: 10.1016/j.wneu.2020.12.081
  • Tang V, Zhu XL, Lau C, et al. Pre-operative cognitive burden as predictor of motor outcome following bilateral subthalamic nucleus deep brain stimulation in parkinson’s disease. Neurol Sci. 2022 Dec;43(12):6803–6811. doi: 10.1007/s10072-022-06370-8
  • Asimakidou E, Xiromerisiou G, Sidiropoulos C. Motor and non-motor outcomes of deep brain stimulation across the genetic panorama of parkinson’s disease: A multi-scale meta-analysis. Mov Disord Clin Pract. [2024 Feb 6];11(5):465–477. doi: 10.1002/mdc3.13994
  • Agelink van Rentergem JA, de Vent NR, Schmand BA, et al. Multivariate normative comparisons for neuropsychological assessment by a multilevel factor structure or multiple imputation approach. Psychol Assess. 2018 Apr;30(4):436–449. doi: 10.1037/pas0000489
  • Hu T, Xie H, Diao Y, et al. Effects of subthalamic nucleus deep brain stimulation on depression in patients with parkinson’s disease. J Clin Med. [2022 Oct 1];11(19):5844. doi: 10.3390/jcm11195844
  • Hacker ML, Tramontana MG, Pazira K, et al. Long-term neuropsychological outcomes of deep brain stimulation in early-stage parkinson’s disease. Parkinsonism Relat Disord. 2023 Aug;113:105479. doi: 10.1016/j.parkreldis.2023.105479
  • Schuepbach WM, Rau J, Knudsen K, et al. Neurostimulation for parkinson’s disease with early motor complications. N Engl J Med. [2013 Feb 14];368(7):610–622. doi: 10.1056/NEJMoa1205158
  • Planas-Ballve A, Vilas D, Pisani A. Cognitive impairment in genetic parkinson’s disease. Parkinsons Dis. 2021;2021:1–11. doi: 10.1155/2021/8610285
  • Alcalay RN, Caccappolo E, Mejia-Santana H, et al. Cognitive performance of gba mutation carriers with early-onset pd: The core-pd study. Neurology. [2012 May 1];78(18):1434–1440. doi: 10.1212/WNL.0b013e318253d54b
  • Wang F, Lai Y, Pan Y, et al. A systematic review of brain morphometry related to deep brain stimulation outcome in parkinson’s disease. NPJ Parkinsons Dis. [2022 Oct 13];8(1):130. doi: 10.1038/s41531-022-00403-x
  • Besse-Pinot E, Pereira B, Durif F, et al. Preoperative rem sleep behavior disorder and subthalamic nucleus deep brain stimulation outcome in parkinson disease 1 year after surgery. Neurology. 2006 [2021 Nov 16];97(20):e1994–e. doi: 10.1212/WNL.0000000000012862
  • Zibetti M, Rizzi L, Colloca L, et al. Probable REM sleep behaviour disorder and stn-dbs outcome in parkinson’s disease. Parkinsonism Relat Disord. 2010 May;16(4):265–269. doi: 10.1016/j.parkreldis.2010.01.001
  • Burchill E, Watson CJ, Fanshawe JB, et al. The impact of psychiatric comorbidity on parkinson’s disease outcomes: A systematic review and meta-analysis. Lancet Reg Health Eur. 2024 Apr;39:100870. doi: 10.1016/j.lanepe.2024.100870
  • Mills KA, Donohue K, Swaminathan A, et al. Neuropsychological predictors of patient-reported cognitive decline after deep brain stimulation in parkinson’s disease. J Clin Exp Neuropsychol. 2019 Apr;41(3):219–228. doi: 10.1080/13803395.2018.1526889
  • Litvan I, Goldman JG, Tröster AI, et al. Diagnostic criteria for mild cognitive impairment in parkinson’s disease: Movement disorder society task force guidelines [Review]. Mov Disord. 2012 Mar;27(3):349–356. doi: 10.1002/mds.24893
  • Tröster AI, Woods SP, Morgan EE. Assessing cognitive change in parkinson’s disease: Development of practice effect-corrected reliable change indices. Arch Clin Neuropsychol. 2007 Aug;22(6):711–718. doi: 10.1016/j.acn.2007.05.004
  • Stebbins GT, Gabrieli JD, Shannon KM, et al. Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced parkinson’s disease. Brain Cogn. 2000;42(3):348–363. doi: 10.1006/brcg.1999.1109
  • Pedersen KF, Larsen JP, Tysnes OB, et al. Natural course of mild cognitive impairment in parkinson disease: A 5-year population-based study. Neurology. [2017 Feb 21];88(8):767–774. doi: 10.1212/WNL.0000000000003634
  • Lawson RA, Yarnall AJ, Duncan GW, et al. Stability of mild cognitive impairment in newly diagnosed parkinson’s disease. J Neurol Neurosurg Psychiatry. 2017 Aug;88(8):648–652. doi: 10.1136/jnnp-2016-315099
  • Santangelo G, Vitale C, Picillo M, et al. Mild cognitive impairment in newly diagnosed parkinson’s disease: A longitudinal prospective study. Parkinsonism Relat Disord. 2015 Oct;21(10):1219–1226. doi: 10.1016/j.parkreldis.2015.08.024
  • Bove F, Fraix V, Cavallieri F, et al. Dementia and subthalamic deep brain stimulation in parkinson disease: A long-term overview. Neurology. [2020 Jul 28];95(4):e384–e392. doi: 10.1212/WNL.0000000000009822
  • Hoogland J, Boel JA, de Bie RMA, et al. Mild cognitive impairment as a risk factor for parkinson’s disease dementia. Mov Disord. 2017 Jul;32(7):1056–1065. doi: 10.1002/mds.27002
  • Hoogland J, Boel JA, de Bie RMA, et al. Risk of parkinson’s disease dementia related to level i mds pd-mci. Mov Disord. 2019 Mar;34(3):430–435. doi: 10.1002/mds.27617
  • Aybek S, Gronchi-Perrin A, Berney A, et al. Long-term cognitive profile and incidence of dementia after stn-dbs in parkinson’s disease. Mov Disord. [2007 May 15];22(7):974–981. doi: 10.1002/mds.21478
  • Block CK, Patel M, Risk BB, et al. Patients with cognitive impairment in parkinson’s disease benefit from deep brain stimulation: A case-control study. Mov Disord Clin Pract. 2023 Mar;10(3):382–391. doi: 10.1002/mdc3.13660
  • Bari AA, Fasano A, Munhoz RP, et al. Improving outcomes of subthalamic nucleus deep brain stimulation in parkinson’s disease. Expert Rev Neurother. 2015 Oct;15(10):1151–1160. doi: 10.1586/14737175.2015.1081815
  • Bot M, Schuurman PR, Odekerken VJJ, et al. Deep brain stimulation for parkinson’s disease: Defining the optimal location within the subthalamic nucleus. J Neurol Neurosurg Psychiatry. 2018 May;89(5):493–498. doi: 10.1136/jnnp-2017-316907
  • Mikos A, Bowers D, Noecker AM, et al. Patient-specific analysis of the relationship between the volume of tissue activated during dbs and verbal fluency. Neuroimage. 2011 Jan;54(Suppl 1):S238–46. doi: 10.1016/j.neuroimage.2010.03.068
  • Holewijn RA, Verbaan D, van den Munckhof PM, et al. General anesthesia vs local anesthesia in microelectrode recording-guided deep-brain stimulation for parkinson disease: The galaxy randomized clinical trial. JAMA Neurol. [2021 Oct 1];78(10):1212–1219. doi: 10.1001/jamaneurol.2021.2979
  • Holewijn RA, Zoon TJC, Verbaan D, et al. Cognitive and psychiatric outcomes in the galaxy trial: Effect of anaesthesia in deep brain stimulation. J Neurol Neurosurg Psychiatry. [2024 Feb 14];95(3):214–221. doi: 10.1136/jnnp-2023-331791
  • Sidiropoulos C, Rammo R, Merker B, et al. Intraoperative mri for deep brain stimulation lead placement in parkinson’s disease: 1 year motor and neuropsychological outcomes. J Neurol. 2016 Jun;263(6):1226–1231. doi: 10.1007/s00415-016-8125-0
  • Brodsky MA, Anderson S, Murchison C, et al. Clinical outcomes of asleep vs awake deep brain stimulation for parkinson disease. Neurology. [2017 Oct 6];89(19):1944–1950. doi: 10.1212/WNL.0000000000004630
  • Reich MM, Hsu J, Ferguson M, et al. A brain network for deep brain stimulation induced cognitive decline in parkinson’s disease. Brain. [2022 May 24];145(4):1410–1421. doi: 10.1093/brain/awac012
  • Dietz J, Noecker AM, McIntyre CC, et al. Stimulation region within the globus pallidus does not affect verbal fluency performance. Brain Stimul. 2013 May;6(3):248–253. doi: 10.1016/j.brs.2012.05.011
  • Leimbach F, Atkinson-Clement C, Wilkinson L, et al. Dissociable effects of subthalamic nucleus deep brain stimulation surgery and acute stimulation on verbal fluency in parkinson’s disease. Behav Brain Res. [2020 Jun 18];388:112621. doi: 10.1016/j.bbr.2020.112621
  • Dembek TA, Reker P, Visser-Vandewalle V, et al. Directional dbs increases side-effect thresholds-a prospective, double-blind trial. Mov Disord. 2017 Oct;32(10):1380–1388. doi: 10.1002/mds.27093
  • Del Bene VA, Martin RC, Brinkerhoff SA, et al. Differential cognitive effects of unilateral subthalamic nucleus deep brain stimulation for parkinson’s disease. Ann Neurol. 2024 Jun;95(6):1205–1219. doi: 10.1002/ana.26903
  • Jain K, Ramesh R, Krishnan S, et al. Cognitive outcome following bilateral subthalamic nucleus deep brain stimulation for parkinson’s disease-a comparative observational study in indian patients. Acta Neurol Belg. 2022 Apr;122(2):447–456. doi: 10.1007/s13760-021-01778-z
  • Hariz MI, Johansson F, Shamsgovara P, et al. Bilateral subthalamic nucleus stimulation in a parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study. Mov Disord. 2000;15(1):136–139. doi: 10.1002/1531-8257(200001)15:1<136:AID-MDS1021>3.0.CO;2-5
  • Hristova A, Lyons K, Tröster AI, et al. Effect and time course of deep brain stimulation of the globus pallidus and subthalamus on motor features of parkinson’s disease. Clin Neuropharmacol. 2000;23(4):208–211. doi: 10.1097/00002826-200007000-00007
  • Swinnen B, Lotfalla V, Scholten MN, et al. Programming algorithm for the management of speech impairment in subthalamic nucleus deep brain stimulation for parkinson’s disease. Technol Neural Interface. 2024 Apr;27(3):528–537. doi: 10.1016/j.neurom.2023.05.002
  • Deshpande N, Hadi M, Ali R. Healthcare disparities in deep brain stimulation access and utilization: a systematic review. J Neurosurg. 2023 Oct;6:1–11.
  • Frassica M, Kern DS, Afshari M, et al. Racial disparities in access to dbs: results of a real-world U.S. claims data analysis. Front Neurol. 2023;14:1233684. doi: 10.3389/fneur.2023.1233684
  • Merola A, Singh J, Reeves K, et al. New frontiers for deep brain stimulation: directionality, sensing technologies, remote programming, robotic stereotactic assistance, asleep procedures, and connectomics. Front Neurol. 2021;12:694747. doi: 10.3389/fneur.2021.694747
  • Ranganathan P, Aggarwal R, Pramesh CS. Common pitfalls in statistical analysis: odds versus risk. Perspect Clin Res. 2015 Oct;6(4):222–224. doi: 10.4103/2229-3485.167092
  • Palmese CA, Wyman-Chick KA, Racine C, et al. Assessment of deep brain stimulation candidacy during the COVID-19 pandemic: Lessons learned and future directions for neuropsychologists. Clin Neuropsychol. 2022 Jan;36(1):72–84. doi: 10.1080/13854046.2021.1929496
  • Jitkritsadakul O, Rajalingam R, Toenjes C, et al. Tele-health for patients with deep brain stimulation: the experience of the ontario telemedicine network. Mov Disord. 2018 Mar;33(3):491–492. doi: 10.1002/mds.27230
  • York MK, Farace E, Pollak L, et al. The global pandemic has permanently changed the state of practice for pre-dbs neuropsychological evaluations. Parkinsonism Relat Disord. 2021 May;86:135–138. doi: 10.1016/j.parkreldis.2021.04.029
  • Backstrom D, Granasen G, Mo SJ, et al. Prediction and early biomarkers of cognitive decline in parkinson disease and atypical parkinsonism: A population-based study. Brain Com. 2022;4(2):fcac040. doi: 10.1093/braincomms/fcac040